The Valley Desk

ArticleHuman vaccines & immunotherapeuticsPublished

Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Human vaccines & immunotherapeutics
Published
Subject terms
Humans; Papillomavirus Infections; Vaccination; Product Surveillance, Postmarketing; Research Design; Adolescent; Adult; Middle Aged; China; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Female
PubMed ID
39445828
PubMed Central ID
PMC11508948
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal